Logo image
Machine Learning Methods and Docking For Predicting Human Pregnane X Receptor Activation
Journal article   Open access   Peer reviewed

Machine Learning Methods and Docking For Predicting Human Pregnane X Receptor Activation

Akash Khandelwal, Matthew D Krasowski, Erica J Reschly, Michael W Sinz, Peter W Swaan and Sean Ekins
Chemical research in toxicology, Vol.21(7), pp.1457-1467
07/2008
DOI: 10.1021/tx800102e
PMCID: PMC2574557
PMID: 18547065
url
https://doi.org/10.1021/tx800102eView
Published (Version of record) Open Access

Abstract

The pregnane X receptor (PXR) regulates the expression of genes involved in xenobiotic metabolism and transport. In vitro methods to screen for PXR agonists are used widely. In the current study, computational models for human PXR activators and PXR non-activators were developed using recursive partitioning (RP), random forest (RF) and support vector machine (SVM) algorithms with VolSurf descriptors. Following 10 fold randomization, the models correctly predicted 82.6 % to 98.9 % of activators and 62.0 % to 88.6 % of non-activators. The models were validated using separate test sets. The overall (n = 15) test set prediction accuracy for PXR activators with RP, RF and SVM PXR models is 80 to 93.3 %, representing an improvement over models previously reported. All models were tested with a second test set (n =145) and prediction accuracy ranged from 63−67 % overall. These test set molecules were found to cover the same area in a principal component analysis plot as the training set, suggesting the predictions were within the applicability domain. The FlexX docking method combined with logistic regression performed poorly in classifying this PXR test set compared with RP, RF and SVM, but may be useful for qualitative interpretion of interactions within the LBD. From this analysis, VolSurf descriptors and machine learning methods had good classification accuracy and made reliable predictions within the model applicability domain. These methods could be used for high throughput virtual screening to assess for PXR activation, prior to in vitro testing to predict potential drug-drug interactions.

Details

Metrics

Logo image